Skip to main content
logo
Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
134.28
0.00 (0.00%)
At close: Jul 27, 2026, 4:00 PM EDT
134.28
0.00 (0.00%)
After-hours: Jul 27, 2026, 4:10 PM EDT

Apogee Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Mar '22
Market Cap
10,0825,1572,6511,416--
Market Cap Growth
325.63%94.55%87.21%---
Enterprise Value
8,8314,4352,1421,02200
Last Close Price
134.2875.4845.3027.94--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Mar '22
PB Ratio
7.965.713.703.73--
P/TBV Ratio
6.805.073.491.84--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Mar '22
Debt / Equity Ratio
0.000.010.010.00--
Net Debt / Equity Ratio
-0.84-0.80-0.71-1.04--
Net Debt / EBITDA Ratio
3.462.542.354.23--
Net Debt / FCF Ratio
4.473.102.955.25--
Quick Ratio
32.1626.1718.2319.24--
Current Ratio
32.5926.5718.5519.38--
Return on Equity (ROE)
-25.41%-31.50%-33.21%-44.21%--
Return on Assets (ROA)
-27.37%-33.74%-37.54%-46.34%--
Return on Invested Capital (ROIC)
-157.97%-146.11%-223.03%---
Return on Capital Employed (ROCE)
-28.14%-34.94%-39.21%-48.84%--

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Mar '22
Buyback Yield / Dilution
-11.13%-9.96%-120.72%-915.57%--
Total Shareholder Return
-11.13%-9.96%-120.72%-915.57%--
SEC Filings: 10-K · 10-Q